This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Fri May 24, 2013 12:30 pm

View unanswered posts | View active topics


Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
squiffy2
PostPosted: Wed Jul 28, 2010 12:41 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1689
Image

German pharmaceutical and chemicals company Merck KGaA has announced that the U.S. Food and Drug Administration accepted a new drug application for its oral multiple sclerosis treatment Cladribine with a priority review designation, after Merck's initial submission was rejected last fall.

Priority review status is applied to drugs that have the potential to provide significant advances in treatment and means the FDA will complete its review in six months rather than the usual 10. Merck expects a decision in the fourth quarter....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. FDA extends priority review of oral MS drug Cladribine

squiffy2

0

868

Fri Nov 26, 2010 3:44 am

squiffy2 View the latest post

There are no new unread posts for this topic. The FDA grants Priority Review status to Anegren

maybelater

3

1339

Mon Jun 28, 2004 11:56 am

Arron View the latest post

There are no new unread posts for this topic. Novartis' Gilenia (FTY720) gets FDA priority review status

squiffy2

2

3288

Mon Feb 22, 2010 11:26 am

euphoniaa View the latest post

There are no new unread posts for this topic. Oral MS drug Cladribine rejected by European drug agency

squiffy2

1

853

Fri Sep 24, 2010 3:27 am

LR1234 View the latest post

There are no new unread posts for this topic. Oral MS drug Cladribine 'Shuts Down MS Activity'

squiffy2

2

926

Thu Jun 10, 2010 5:57 am

viper498 View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: